IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Takeda Pharmaceutical Co LTD

Q2 2025 Holdings

Filed 2025-08-08 | 12 holdings | $19.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
HilleVax, Inc.COM43157M102$13.4M6,724,00068.4%
Ovid Therapeutics, Inc.(OVID)COM690469101$2.5M7,531,99612.7%
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)(XLO)COM98422T100$1.0M1,475,1215.1%
American Well Corporation(AMWL)COM03044L204$691.1K77,7333.5%
Equillium, Inc.(EQ)COM29446K106$575.2K1,824,9772.9%
Shattuck Labs, Inc.(STTK)COM82024L103$408.3K515,6192.1%
Lyell Immunopharma, Inc.COM55083R104$363.9K41,1651.9%
Turnstone BiologicsCOM90042W100$321.6K895,8241.6%
Third Harmonic Bio, Inc.(THRD)COM88427A107$200.0K36,8351.0%
Rani Therapeutics Holdings, Inc.(RANI)COM753018100$104.4K203,1900.5%
Standard Biotools, Inc.(LAB)COM34385P108$19.8K16,5150.1%